Pharmacogenomics & Personalized Medicine

杂志介绍

Pharmacogenomics & Personalized Medicine杂志介绍

《Pharmacogenomics & Personalized Medicine》是一本以English为主的开放获取国际优秀期刊，中文名称药物基因组学和个性化医学，本刊主要出版、报道医学-PHARMACOLOGY & PHARMACY领域的研究动态以及在该领域取得的各方面的经验和科研成果，介绍该领域有关本专业的最新进展，探讨行业发展的思路和方法，以促进学术信息交流，提高行业发展。该刊已被国际权威数据库SCIE收录，为该领域相关学科的发展起到了良好的推动作用，也得到了本专业人员的广泛认可。该刊最新影响因子为1.8，最新CiteScore 指数为3.3。

本刊近期中国学者发表的论文主要有：

• Resistance to PARP Inhibitors After First-Line Platinum-Based Chemotherapy in a Patient with Advanced Ovarian Cancer with a Pathogenic Somatic BRCA1 Mutation

  Author: Zhong, Lan; Yin, Rutie; Song, Liang

• Identification and Validation of Ferroptosis-Related Subtypes and a Predictive Signature in Hepatocellular Carcinoma

  Author: Zheng, Chunlan; Peng, Yanan; Wang, Haizhou; Wang, Youwei; Liu, Lan; Zhao, Qiu

• NOTCH2, ATIC, MRI1, SLC6A13, ATP13A2 Genetic Variations are Associated with Ventricular Septal Defect in the Chinese Tibetan Population Through Whole-Exome Sequencing

  Author: Zhang, Xiaohui; Zhen, Da; Li, Xuemei; Yi, Faling; Zhang, Zhanhao; Yang, Wei; Li, Xuguang; Sheng, Yemeng; Liu, Xiaoli; Jin, Tianbo; He, Yongjun

• The Allelic Expression of RNA Editing Gene ADARB1 in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization

  Author: Zeng, Jiajia; Han, Linyu; Wang, Teng; Huang, Linying; Zheng, Yanxiu; Zhang, Nasha; Li, Ziqiang; Yang, Ming

英文介绍

Pharmacogenomics & Personalized Medicine杂志英文介绍

Pharmacogenomics and Personalized Medicine is an international, peer-reviewed, open-access journal characterizing the influence of genotype on pharmacology leading to the development of personalized treatment programs and individualized drug selection for improved safety, efficacy and sustainability.

In particular, emphasis will be given to:

Genomic and proteomic profiling

Genetics and drug metabolism

Targeted drug identification and discovery

Optimizing drug selection & dosage based on patient's genetic profile

Drug related morbidity & mortality intervention

Advanced disease screening and targeted therapeutic intervention

Genetic based vaccine development

Patient satisfaction and preference

Health economic evaluations

Practical and organizational issues in the development and implementation of personalized medicine programs.